Selective estrogen receptor modulators (SERMs) affect cholesterol homeostasis through the master regulators SREBP and LXR

Publication date: September 2021Source: Biomedicine & Pharmacotherapy, Volume 141Author(s): María E. Fernández-Suárez, Lidia Daimiel, Gemma Villa-Turégano, María Vázquez Pavón, Rebeca Busto, Joan C. Escolà-Gil, Frances M. Platt, Miguel A. Lasunción, Javier Martínez-Botas, Diego Gómez-Coronado
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research